Receptor-mediated gene delivery using bacteriophage vectors
US7148202B2 · kind B2 · utility
2Cited by
7References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2002 |
| Grant date | Dec 12, 2006 |
| Priority date | — |
| Expiry date | Nov 6, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2810/851
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Filamentous phage particles displaying a ligand on their surface are used to deliver a therapeutic gene to a cell. The ligand is a fusion protein with a phage capsid protein, covalently conjugated to phage particles, or complexed with modified phage particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.